RECRUITING

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients with Breast Cancer Undergoing Breast Surgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.

Official Title

Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: the Impact on Out of Pocket Costs, Lost Wages and Economic Strain

Quick Facts

Study Start:2019-05-21
Study Completion:2026-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04169542

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history
  2. * English-speaking
  3. * Able to complete consent
  4. * Able to fill out computer survey material
  1. * Non-English-speaking
  2. * Those with recurrent or metastatic disease or concurrent primary cancers
  3. * Patients undergoing breast conservation therapy will also be excluded from the study

Contacts and Locations

Study Contact

Carrie Chu, MD
CONTACT
713-794-1247
ckchu@mdanderson.org

Principal Investigator

Carrie Chu, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson in The Woodlands
Conroe, Texas, 77384
United States
M D Anderson Cancer Center
Houston, Texas, 77030
United States
MD Anderson League City
League City, Texas, 77573
United States
MD Anderson in Sugar Land
Sugar Land, Texas, 77478
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Carrie Chu, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-05-21
Study Completion Date2026-03-31

Study Record Updates

Study Start Date2019-05-21
Study Completion Date2026-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Ductal Carcinoma in Situ
  • COVID-19 Infection
  • Hereditary Breast Carcinoma
  • Invasive Breast Carcinoma